1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 17 AUGUST 2015

Cancer Drug News 17 AUGUST 2015

  • August 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Checkpoint Inhibitors Will Assert Dominance Over New Wave Of Immuno-Oncology
Industry Brief - Onconova Submits IND For Phase III Trial Of IV Rigosertib In HR-MDS
Industry Brief - FDA Approves Sprycel Label Update
Industry Brief - Alvogen Launches Bortezomib In Bulgaria
Industry Trend Analysis - Venetoclax Will Bolster AbbVie's Strategically Important Haematological Cancer Franchise
Industry Brief - Immune Design/Merck Enter Immuno-Oncology Clinical Trial Collaboration
Industry Brief - Poseida Licenses Janssen's Centyrin Technology To Develop CAR Therapies
Industry Brief - Genentech's Atezolizumab Phase II LC Study Meets Primary Endpoint
Industry Brief - Threshold Begins First Tarloxotinib Phase II Trial In EGFr-Mutant T790M-Negative NSCLC
Industry Brief - Clovis/Genentech Enter Clinical Trial Collaboration In Advanced NSCLC
Industry Brief - Hikma Challenges Abiraterone Patent
Industry Brief - Unituxin Gains EU Approval For Paediatric High-Risk Neuroblastoma
Industry Brief - ImmunoCellular/FDA Reach SPA Agreement On ICT-107 Phase III Glioblastoma Trial
Industry Brief - FDA Extends Action Date For Opdivo sBLA In Advanced Melanoma
Industry Trend Analysis - Mallinckrodt To Expand Hospital Growth Platform With Therakos Acquisition
Industry Trend Analysis - Importance Of Industry/Academia Partnership Increasing
Industry Brief - Genmab Licenses DuoBody Platform To Novo Nordisk
Industry Brief - Janssen Licenses TNF Receptor Superfamily Targeted Agent From Alligator
Industry Brief - Checkmate Secures Funding For Development Of Immuno-Oncology Products
Industry Trend Analysis - Pfizer/Hospira Growth Prospects Undiminished Despite EC Biosimilar Ruling

Table Of Contents

Cancer Drug News 17 AUGUST 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Hematological Malignancies Market: Overview This report provides in-depth region wise and country wise analysis of the hematological malignancies market. Stakeholders of this report include manufacturers ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.